Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

NCT00406393

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +21 more
Locations: City of Hope National Medical Center Duarte, California, United States

UCSD Medical Center La Jolla, California, United States

Stanford Hospital and Clinics Stanford, California, United States

University of Florida College of Medicine (Shands) Gainesville, Florida, United States

View all 24 locations

View Trial Details

Completed

Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT

NCT04629430

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +42 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

NCT00423514

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +31 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

NCT03393611

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Unrelated Donor Stem Cell Transplantation

NCT01364363

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Anemia, +47 more
Locations: Scripps Green Hospital La Jolla, California, United States

View Trial Details

Completed

Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients

NCT04676945

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Hanusch Krankenhaus, 3.Medizinische Abteilung Vienna, Austria

View Trial Details

Completed

A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT04543305

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Florida Cancer Specialists Lake Mary, Florida, United States

Florida Cancer Specialists Sarasota, Florida, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT00614523

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +5 more
Locations: Not specified

View Trial Details

Completed

Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)

NCT03140280

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

NCT01736683

Conditions: Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations: Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Johns Hopkins Baltimore, Maryland, United States

Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States

View all 20 locations

View Trial Details